Least developed countries vs Sweden: Access to anti-retroviral drugs, male
Least developed countries
80.9%
in 2024
Sweden
95.0%
in 2022
Least developed countries rank
2nd
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- Least developed countries
- Sweden
How they compare
Sweden currently reports 95.0% against 80.9% in Least developed countries, a difference of 14.1%.
That makes Sweden's figure about 1.2 times Least developed countries's.
Across all 23 years both countries report, Sweden has been ahead every year.
Least developed countries ranks 2nd and Sweden ranks 4th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Least developed countries | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 53.7% | 48.0% | Sweden |
| 2010s | 40.1% | 92.5% | 52.4% | Sweden |
| 2020s | 69.6% | 95.3% | 25.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Least developed countries or Sweden?
- Sweden, at 95.0% against 80.9% in Least developed countries as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Least developed countries and Sweden?
- 14.1%, with Sweden ahead.
- How many years of comparable data are there for Least developed countries and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Least developed countries and Sweden rank globally for access to anti-retroviral drugs, male?
- Least developed countries ranks 2nd and Sweden ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.